Pfizer (PFE) Gross Margin (2009 - 2026)
Pfizer (PFE) posted Gross Margin of 72.78% for Q2 2026, down 1.44 percentage points from 74.22% a year earlier and down 2.67 percentage points from the prior quarter.
Pfizer (PFE) Gross Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 28, 2026, Gross Margin at Pfizer was 73.18%, up 1.06 percentage points year-over-year; for FY2025, it came in at 74.33%, up 2.38 percentage points from FY2024.
- Annual Gross Margin shows a five-year change of -5.31 percentage points (FY2020 to FY2025).
- In prior years, Pfizer's Gross Margin was 71.94% in FY2024 (+13.85 pp), 58.10% in FY2023 (-7.96 pp), 66.05% in FY2022 (+3.97 pp) and 62.08% in FY2021 (-17.55 pp).
- Quarterly Gross Margin has run from a low of 48.09% in Q4 2023 to a high of 79.26% in Q1 2025 over five years.
- On a year-over-year basis, Gross Margin increased in four of the last seven quarters, with an average year-over-year change of +3.19 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2024, with a gain of 18.65 percentage points; the weakest was Q3 2021, with a drop of 21.79 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 75.45% (Q1 2026), 69.97% (Q4 2025) and 74.95% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 71.28% |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 72.78% |
| Mar 29, 2026 | 75.45% |
| Dec 31, 2025 | 69.97% |
| Sep 28, 2025 | 74.95% |
| Jun 29, 2025 | 74.22% |
| Mar 30, 2025 | 79.26% |
| Dec 31, 2024 | 66.73% |
| Sep 29, 2024 | 70.27% |
| Jun 30, 2024 | 75.16% |
| Mar 31, 2024 | 77.29% |
| Dec 31, 2023 | 48.09% |
| Jul 2, 2023 | 75.11% |
| Apr 2, 2023 | 73.57% |
| Jul 3, 2022 | 68.83% |
| Apr 3, 2022 | 61.09% |
| Oct 3, 2021 | 58.68% |
| Jul 4, 2021 | 62.98% |
| Apr 4, 2021 | 71.36% |
| Dec 31, 2020 | 76.28% |
| Sep 27, 2020 | 80.47% |
Pfizer Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();